UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer

Cancer & metabolism, 2023-02, Vol.11 (1), p.3-14, Article 3

2023

Volltextzugriff (PDF)

Methylated genes as new cancer biomarkers

European journal of cancer (1990), 2009-02, Vol.45 (3), p.335-346

2009

Volltextzugriff (PDF)

Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia

European journal of cancer (1990), 2013-03, Vol.49 (4), p.860-867

2013

Volltextzugriff (PDF)

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

British journal of cancer, 2008-11, Vol.99 (10), p.1644-1650

2008

Volltextzugriff (PDF)

Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study

BJOG : an international journal of obstetrics and gynaecology, 2012-11, Vol.119 (12), p.1465-1472

2012

Volltextzugriff (PDF)

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group

European journal of cancer (1990), 2009-01, Vol.45 (1), p.74-81

2009

Volltextzugriff (PDF)

Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids

International journal of oncology, 2014-04, Vol.44 (4), p.1394-1400

2014

Volltextzugriff (PDF)

Independent and functional validation of a multi-tumour-type proliferation signature

British journal of cancer, 2012-07, Vol.107 (3), p.508-515

2012

Volltextzugriff (PDF)

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

JNCI : Journal of the National Cancer Institute, 2002-01, Vol.94 (2), p.116-128

2002

Volltextzugriff (PDF)

Angiostatin generation by human tumor cell lines: Involvement of plasminogen activators

International journal of cancer, 2000-06, Vol.86 (6), p.760-767

2000

Volltextzugriff (PDF)

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

European journal of cancer (1990), 2013-05, Vol.49 (8), p.1825-1835

2013

Volltextzugriff (PDF)

TRPM7 Is Required for Breast Tumor Cell Metastasis

Cancer research (Chicago, Ill.), 2012-08, Vol.72 (16), p.4250-4261

2012

Volltextzugriff (PDF)

Production of 11-Oxygenated Androgens by Testicular Adrenal Rest Tumors

The journal of clinical endocrinology and metabolism, 2022-01, Vol.107 (1), p.e272-e280

2022

Volltextzugriff (PDF)

Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer

Journal of clinical oncology, 2006-04, Vol.24 (11), p.1665-1671

2006

Volltextzugriff (PDF)

Secondary Ovarian Malignancies: Frequency, Origin, and Characteristics

International journal of gynecological cancer, 2009-10, Vol.19 (7), p.1160-1165-1165

2009

Volltextzugriff (PDF)

Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline

Critical reviews in oncology/hematology, 2012-11, Vol.84 (2), p.252-260

2012

Volltextzugriff (PDF)

Molecular profiling of platinum resistant ovarian cancer

International journal of cancer, 2006-04, Vol.118 (8), p.1963-1971

2006

Volltextzugriff (PDF)

Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach

Investigational new drugs, 2013-08, Vol.31 (4), p.881-890

2013

Volltextzugriff (PDF)

Antibody GD3G7 Selected against Embryonic Glycosaminoglycans Defines Chondroitin Sulfate-E Domains Highly Up-Regulated in Ovarian Cancer and Involved in Vascular Endothelial Growth Factor Binding

The American journal of pathology, 2007-10, Vol.171 (4), p.1324-1333

2007

Volltextzugriff (PDF)

The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer

European journal of clinical investigation, 2010-07, Vol.40 (7), p.591-599

2010

Volltextzugriff (PDF)

Serum vascular endothelial growth factor: a prognostic factor in cervical cancer

Journal of cancer research and clinical oncology, 2009-02, Vol.135 (2), p.283-290

2009

Volltextzugriff (PDF)

Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer

International journal of cancer, 2008-10, Vol.123 (8), p.1848-1853

2008

Volltextzugriff (PDF)

Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors

Journal of cancer research and clinical oncology, 2010-05, Vol.136 (5), p.771-778

2010

Volltextzugriff (PDF)

The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (Review)

International journal of oncology, 2008-06, Vol.32 (6), p.1145-1157

2008

Volltextzugriff (PDF)

External validation of serum hCG cutoff levels for prediction of resistance to single-agent chemotherapy in patients with persistent trophoblastic disease

British journal of cancer, 2009-03, Vol.100 (6), p.979-984

2009

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer

Methylated genes as new cancer biomarkers

Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia

Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA

Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group

Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids

Independent and functional validation of a multi-tumour-type proliferation signature

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Angiostatin generation by human tumor cell lines: Involvement of plasminogen activators

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

TRPM7 Is Required for Breast Tumor Cell Metastasis

Production of 11-Oxygenated Androgens by Testicular Adrenal Rest Tumors

Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer

Secondary Ovarian Malignancies: Frequency, Origin, and Characteristics

Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline

Molecular profiling of platinum resistant ovarian cancer

Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach

Antibody GD3G7 Selected against Embryonic Glycosaminoglycans Defines Chondroitin Sulfate-E Domains Highly Up-Regulated in Ovarian Cancer and Involved in Vascular Endothelial Growth Factor Binding

The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer

Serum vascular endothelial growth factor: a prognostic factor in cervical cancer

Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer

Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors

The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (Review)

External validation of serum hCG cutoff levels for prediction of resistance to single-agent chemotherapy in patients with persistent trophoblastic disease

Aktive Filter

Suchergebnisse filtern